A Chance to Try it Out

Jan 27, 2009

The US Food and Drug Administration approved biotech firm Geron's application to conduct a clinical trial of a human embryonic stem cell therapy. The decision came days after President Obama was inaugurated though Geron and FDA representatives say the timing is coincidental.

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.